comparemela.com

Latest Breaking News On - Systematix group - Page 8 : comparemela.com

Intas Pharma s Ahmedabad Facility Gets Import Alert From US FDA

An import alert prevents the company from distributing products in the United States. As of now, Intas has been allowed to supply 24 critical products that are in short supply in the US, after completing the necessary testing, verification and compliance

India s pharmacy Of The World Moniker Is Under Threat Here s Why

Indian Pharma: What Is The Future Of Generic Drug Makers In India?

Daily Voice | Dhananjay Sinha of Systematix Group expects valuation multiples to remain under pressure

Turn defensive or buy the dips? Covid leaves investors confused

Turn defensive or buy the dips? Covid leaves investors confused SECTIONS Share Synopsis The Delhi government has imposed night curfew to check a surge in Covid cases, but said it was not considering lockdown. The Nifty50 and BSE Sensex index are down over 2% this week while the fear gauge India VIX has soared some 12%. Related MUMBAI: Monday’s panic selling in the domestic equity market and weakness seen thereafter following stricter lockdown measures in Maharashtra, India’s richest state, and in some other parts of the country may provide opportunities for investors to accumulate quality stocks with long runway for growth, said analysts and money managers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.